Reproductive rights advocates wanted to remind Pennsylvania residents that access to the medicine is still legal and that those seeking it should still talk to a health care provider.
In Missouri, Republicans have introduced bills to charge women who have abortions with murder, while in Texas, a mom was forced to flee the state to get an abortion in order to protect her own health—situations made possible by Donald Trump and the repeal of Roe v. Wade.
These wins indicate that reproductive rights remain a potent issue for voters heading into the 2024 presidential election.
Before being elected to Congress, Mike Johnson tried to shut down an abortion clinic in Louisiana. After Roe v. Wade was overturned, Johnson called it a “historic and joyful” day and later expressed support for nationwide abortion ban. Now, he’s the new Speaker of the House.
Although these pharmacies dispensing the drug marks a victory for reproductive freedom, a looming Supreme Court case could cut off access to the medication in states where abortion is still legal.
Opill is the first ever birth control pill to be approved for over-the-counter sales. The medication will likely become available at stores and online retailers in the U.S. in early 2024.
Women have suffered through ectopic pregnancies, miscarriages, fetal anomalies, and other complications, but have found it difficult to get the care they need due to restrictive abortion bans.
The 5th Circuit’s ruling maintains mifepristone’s availability for now, but severely limits access in ways that could harm patients seeking abortion care.
Access to the abortion medication mifepristone has been called into question following the issuance of competing rulings in Texas and Washington.
